Skip to main content

Status of lung cancer in India

Lung cancer is one of the leading causes of death all around the world and is especially rampant in India. It is a fear-inducing disease due to its debilitating, terminal consequences. In India, lung cancer has been one of the leading causes of cancer-related deaths for a long time. In fact, the Indian Council of Medical Research (ICMR) has estimated that it accounts for roughly one-sixth of all deaths due to cancer in the country.


Prevalence of this widespread disease


The exact reason for the high prevalence of the disease in India is not definitively known, but experts have cited factors such as air pollution, the use of tobacco products, and industrial hazardous materials being thrown into the environment as some of the strongest suspects. With air pollution being especially severe in many of the bigger cities, this has also led to an increased risk of lung cancer amongst the Indian population. Furthermore, India is also one of the biggest exporters of tobacco products in the world, which indirectly affects the population's overall health and increases the chances of people developing the devastating disease.


The initiative from governments and organizations worldwide


Though the numbers are relatively better compared to the rest of the world, they are still causing concern. As a result, many organizations and governmental bodies have taken measures to tackle lung cancer in India by raising awareness and educating people about the risks and side effects of using these harmful products. Organizations such as IGCS (International Germ Cell Symposium), The Indian Cancer Society, and FORCE (Foundation for Research on Carcinogenesis and Chemoprevention) are just some of the many organizations that are actively playing their part in this cause.

 

In addition to that, the Government of India has also taken steps to minimize the prevalence of lung cancer in the country by trying to minimize air pollution, banning harmful tobacco products, and providing free treatment to people in need. Despite all these government and non-governmental interventions, the number of cases of lung cancer in India still remains high. Therefore, it is important that we all become more aware of the risks associated with the disease and work together to help curb its prevalence.


Treatment as a cure


Gefitinib 250mg Tablet is a prescription medication used to treat non-small-cell lung cancer (NSCLC). It belongs to a class of medications known as tyrosine kinase inhibitors. It works by blocking tyrosine kinase enzymes, which are substances in the body responsible for the growth, spread, and proliferation of cancer cells. Gefitinib 250mg Tablet uses to decrease the growth of cancer cells and can help improve overall survival.


Dose of administration


Gefitinib 250mg Tablet is typically administered orally, once daily. It is usually taken on an empty stomach at least one hour before a meal or two hours after a meal. The tablets should be swallowed whole and should not be crushed or chewed. If a dose is missed, it should not be taken in the evening or near bedtime to prevent problems sleeping.


Effects as a possible precaution


Gefitinib 250mg Tablet is generally well-tolerated but side effects can occur in some individuals. Side effects can range from mild to severe and can include fatigue, diarrhea, nausea, rash, and headache. Other rare but serious side effects may include liver problems, heart and lung problems, skin infection, bone marrow suppression, and vision or hearing problems.


Talk to your doctor or healthcare professional


Before taking Gefitinib 250mg Tablet, it is important to talk to your doctor about any medical conditions you have, any other medications or supplements you take, and any potential drug interactions that may be present. Other important things to consider include allergies, age, and kidney or liver impairment. Pregnant or breastfeeding women should also discuss any possible risks with their doctor.


Discuss before taking this dosage


Gefitinib 250mg Tablet is generally well-tolerated when taken as prescribed. However, side effects can occur. All potential risks and side effects should be discussed with a doctor before taking Gefitinib 250mg Tablet. With regular use and appropriate follow-up, Gefitero 250mg Tablet can help increase overall survival in people with non-small-cell lung cancer.


Conclusion

Overall, it can be seen that the status of lung cancer in India is particularly alarming and is a pressing public health concern. It is high time that all of us come together and work collectively to tackle this problem before it is too late.

  

Comments

Post a Comment

Popular posts from this blog

Prostate Cancer

Prostate cancer is a type of cancer that occurs in the prostate gland in men. The prostate is a walnut-shaped small gland and part of the reproductive system in males that makes seminal fluid. It nourishes and sends sperm. Prostate cancer is a common form of cancer. The growth of prostate cells can be slow and restricted to your prostate gland. In that case, it may not lead to serious damage, or even you do not need treatment.  Early detection of prostate cancer can make treatment successful. What are the symptoms of prostate cancer? Prostate cancer may not lead to any signs or symptoms in its early stages. In advanced stages, it can show signs and symptoms, such as. ●   Feel difficulty while urinating. ●   Having blood in the urine. ●   Having blood in the semen. ●   Pain in bone. ●   Loss of appetite ●   Weight loss ●   Painful ejaculation. ●   Lower back, hips, or upper thigh pain. ●   Feel dull pain in the pelvic zone. What are the ...
Post a Comment
Read more

Role of Alectinib

Alectinib is a novel FDA-approved, targeted therapy used to treat ALK(anaplastic lymphoma kinase)-positive advanced non-small-cell lung cancer (NSCLC). NSCLC is the most common type of lung cancer and is the leading cause of cancer-related deaths worldwide. ALK-positive NSCLC is a rare and aggressive form of lung cancer caused by a genetic abnormality in the ALK gene. Alectinib works by specifically targeting the cancer cells with the abnormal ALK gene, potentially providing a more personalized approach to treating NSCLC. Dosage of alectinib administration Alectinib is administered as a once-daily 150mg dose either orally or intravenously. It is combined with other drugs such as chemotherapy, immunotherapy, and other targeted therapies following the progression or recurrence of the disease. Alectinib has displayed superior efficacy in comparison to other existing ALK inhibitors such as crizotinib, with higher response and progression-free survival rates. Side effects due to alectinib A...
Post a Comment
Read more

Everything You Need To Know About MLM Software

  Efficient Management: MLM businesses often have complex structures with multiple levels of distributors and compensation plans. MLM software helps efficiently manage these intricate networks by automating tasks, calculating commissions, and tracking sales volumes. Real-time Reporting: MLM software provides real-time reports and analytics, enabling business owners and distributors to monitor performance, track sales trends, and make data-driven decisions. Streamlined Communication:  MLM software offers  communication tools like messaging and notifications, enhancing communication between the company and its distributors. It facilitates seamless information exchange and ensures everyone is on the same page. Security and Data Privacy: MLM software ensures data security and privacy by implementing robust encryption methods and access controls, protecting the sensitive information of both the company and its distributors. Scalability: As MLM businesses grow, their needs evol...
Post a Comment
Read more